Associated Papers
Genetic Testing for Primary Aldosteronism in SPAIN: Results From the SPAIN-ALDO Registry and Review of the Literature.
Araujo-Castro M et al.
The Journal of Clinical Endocrinology and Metabolism, 2025
KCNJ5 mutations in familial and non-familial primary aldosteronism.
Al-Salameh A
European Journal of Endocrinology, 2024
Familial hyperaldosteronism: an European Reference Network on Rare Endocrine Conditions clinical practice guideline.
Mulatero P et al.
European Journal of Endocrinology, 2024
Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism.
Araujo-Castro M et al.
Frontiers in Endocrinology, 2024
Primary aldosteronism: molecular medicine meets public health.
Azizan EAB et al.
Nature Reviews. Nephrology, 2023
Relevance of KCNJ5 in Pathologies of Heart Disease.
Meyer KM et al.
International Journal of Molecular Sciences, 2023
Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas.
Pitsava G et al.
Current Cardiology Reports, 2022
Determinants of trafficking, conduction, and disease within a K+ channel revealed through multiparametric deep mutational scanning.
Coyote-Maestas W et al.
Elife, 2022
Pathogenesis of Primary Aldosteronism: Impact on Clinical Outcome.
Santana LS et al.
Frontiers in Endocrinology, 2022
Progress on Genetic Basis of Primary Aldosteronism.
Karwacka I et al.
Biomedicines, 2021
Genome-wide association study of antipsychotic-induced sinus bradycardia in Chinese schizophrenia patients.
Weng S et al.
Plos One, 2021
Pathogenesis and treatment of primary aldosteronism.
Zennaro MC et al.
Nature Reviews. Endocrinology, 2020
Primary aldosteronism diagnostics: KCNJ5 mutations and hybrid steroid synthesis in aldosterone-producing adenomas.
Rege J et al.
Gland Surgery, 2020
Genetic causes of primary aldosteronism.
Seidel E et al.
Experimental & Molecular Medicine, 2019
A de novo mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset hypertension.
Shi X et al.
Journal of Hypertension, 2019
Na/K Pump Mutations Associated with Primary Hyperaldosteronism Cause Loss of Function.
Meyer DJ et al.
Biochemistry, 2019
Familial hyperaldosteronism type III a novel case and review of literature.
Pons Fernández N et al.
Reviews in Endocrine & Metabolic Disorders, 2019
Inherited Forms of Primary Hyperaldosteronism: New Genes, New Phenotypes and Proposition of A New Classification.
Perez-Rivas LG et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association, 2019
Familial Sinus Node Disease Caused by a Gain of GIRK (G-Protein Activated Inwardly Rectifying K+ Channel) Channel Function.
Kuß J et al.
Circulation. Genomic and Precision Medicine, 2019
GENETICS IN ENDOCRINOLOGY: The expanding genetic horizon of primary aldosteronism.
Monticone S et al.
European Journal of Endocrinology, 2018
Genetic Causes of Functional Adrenocortical Adenomas.
Zennaro MC et al.
Endocrine Reviews, 2017
Familial hyperaldosteronism type III.
Monticone S et al.
Journal of Human Hypertension, 2017
A Novel Case of Somatic KCNJ5 Mutation in Pediatric-Onset Aldosterone-Producing Adenoma.
Uchida N et al.
Journal of the Endocrine Society, 2017
Of channels and pumps: different ways to boost the aldosterone?
Bandulik S
Acta Physiologica (oxford, England), 2017
Somatic and inherited mutations in primary aldosteronism.
Fernandes-Rosa FL et al.
Journal of Molecular Endocrinology, 2017
Disordered zonal and cellular CYP11B2 enzyme expression in familial hyperaldosteronism type 3.
Gomez-Sanchez CE et al.
Molecular and Cellular Endocrinology, 2017
Genetics of primary hyperaldosteronism.
Dutta RK et al.
Endocrine-related Cancer, 2016
SFE/SFHTA/AFCE consensus on primary aldosteronism, part 5: Genetic diagnosis of primary aldosteronism.
Zennaro MC et al.
Annales D'endocrinologie, 2016
An Update on Familial Hyperaldosteronism.
Korah HE et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme, 2015
Inherited forms of mineralocorticoid hypertension.
Zennaro MC et al.
Best Practice & Research. Clinical Endocrinology & Metabolism, 2015
The molecular basis of primary aldosteronism: from chimeric gene to channelopathy.
Lenzini L et al.
Current Opinion in Pharmacology, 2015
Prevalence and characterization of somatic mutations in Chinese aldosterone-producing adenoma patients.
Wang B et al.
Medicine, 2015
[Genetic alterations in primary aldosteronism].
Zennaro MC et al.
Medecine Sciences : M/s, 2015
KCNJ5 mutations are the most frequent genetic alteration in primary aldosteronism.
Williams TA et al.
Hypertension (dallas, Tex. : 1979), 2015
An update on novel mechanisms of primary aldosteronism.
Zennaro MC et al.
The Journal of Endocrinology, 2015
Understanding primary aldosteronism: impact of next generation sequencing and expression profiling.
Monticone S et al.
Molecular and Cellular Endocrinology, 2015
Update in primary aldosteronism.
Stowasser M
The Journal of Clinical Endocrinology and Metabolism, 2015
A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
Kuppusamy M et al.
The Journal of Clinical Endocrinology and Metabolism, 2014
Pharmacology and pathophysiology of mutated KCNJ5 found in adrenal aldosterone-producing adenomas.
Tauber P et al.
Endocrinology, 2014
Discordant genotype-phenotype correlation in familial hyperaldosteronism type III with KCNJ5 gene mutation: a patient report and review of the literature.
Adachi M et al.
Hormone Research in Paediatrics, 2014
a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III.
Monticone S et al.
The Journal of Clinical Endocrinology and Metabolism, 2013